Initial Director’s Interest Notice – Dianne Angus
May 11, 2020
Imagion Biosystems Limited has announced “Appendix 3X: Initial Director’s Interest Notice.” Read Appendix 3X.
Category: Investor updates
Imagion Appoints New Non-Executive Director
May 11, 2020
Imagion Biosystems Limited today announced the appointment of Ms Dianne Angus to the Board of Directors. Ms Angus joined the Board as a Non-Executive Director
Imagion Directors Take Up Entitlement in Rights Offers
May 1, 2020
Five Appendices 3Y, “Change of Director’s Interest Notice”, have been released to announce the entitlement right offers taken up by Imagion Directors. Read the Appendices
Appendix 4G
April 30, 2020
Imagion Biosystems has released Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations. Read Appendix 4G
Annual Report to Shareholders
April 30, 2020
Imagion Biosystems has released its Annual Report to Shareholders for the year ended 31 December 2019. Read the Annual Report.
Appendix 2A – Vesting of Performance Rights
April 29, 2020
Imagion Biosystems announces that Appendix 2A – Vesting of Performance Rights has been released to the market. Read Appendix 2A – Vesting of Performance Rights.
Appendix 2A — Renounceable Rights Issue and Placement
April 28, 2020
Imagion Biosystems has announced Appendix 2A — Application for quotation of +securities. Read Appendix 2A.
Imagion Biosystems Updates Capital Raise to $2.5 Million
April 28, 2020
Imagion Biosystems Limited previously advised that the Renounceable Rights Issue announced on 25 March 2020 (“Offer”) has closed oversubscribed and raised $2.05 million. To accommodate
Second Supplementary Prospectus
April 28, 2020
Imagion Biosystems has announced a Secondary Supplementary Prospectus. Read the Secondary Supplementary Prospectus.
Proposed Issue of Securities
April 28, 2020
Imagion Biosystems has announced a Proposed Issue of Securities. Read the Proposed Issue of Securities.